Dr. Vitolo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
15 Parkman St
WACC 815
Boston, MA 02114Phone+1 617-724-5600- Is this information wrong?
Education & Training
- Harvard Medical SchoolM.M.Sc., Translational Medicine, 2010 - 2012
- Brigham and Women's HospitalBehavioral Neurology and Neuropsychiatry, 2008 - 2009
- Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 2004 - 2008
- Sapienza University of RomeClass of 1998
Certifications & Licensure
- MA State Medical License 2008 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- United Council for Neurologic SubspecialtiesBehavioral Neurology and Neuropsychiatry
Clinical Trials
- Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression Start of enrollment: 2012 Apr 01
Publications & Presentations
PubMed
- "When Will All of This End?": A 65-Year-Old Man With Amyotrophic Lateral Sclerosis and Psychiatric Distress.Lester, E., Cramer, M., Harley, R., Cohen, J., Vitolo, O., Flaherty, A., Beaussant, Y.> ;The Journal of Clinical Psychiatry. 2023 Dec 13
- Resilient together-ALS: leveraging the NDD transdiagnostic framework to develop an early dyadic intervention for people with amyotrophic lateral sclerosis and their in...Christina L Rush, Ethan G Lester, Heena Manglani, Emily Woodworth, Ottavio Vitolo, Maurizio Fava, James D Berry, Kate Brizzi, Suma Babu, Elizabeth C Lindenberger, J Ra...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Jun 22
- When real life conditions do not follow textbook diagnosis: A diagnostic challenge from a neuropsychiatric clinicMahdi Razafsha, Karen Buch, Ottavio V. Vitolo, Zeina Chemali> ;International Journal of Psychiatry in Medicine. 2021 Nov 1
- Join now to see all
Press Mentions
- Relmada Therapeutics Stock Soars on Phase 2 Depression Study ResultsOctober 15th, 2019
- Relmada Therapeutics Announces Publication of REL1017 Phase 1 Studies ResultsApril 16th, 2019
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: